Research.Patient.info
Immunoglobulin A (IgA) nephropathy research hub
2 indexed studies · 2 currently recruiting
- recruitingNot Applicable
Real-world experience of patients with IgA nephropathy treated with sparsentan through an Early Access Program in the UK
This study looks at how a kidney medicine called sparsentan works in routine NHS care. Researchers are studying medical records of adults with IgA nephropathy who received the treatment through an early access scheme. The study uses existing health notes and requires no extra hospital appointments or tests.
United Kingdom · England · Scotland - recruitingPHASE1, PHASE2
PS-002 for the Treatment of IgA Nephropathy in Adults
This study investigates a new treatment, PS-002, for IgA nephropathy, a kidney condition. It's an early-stage trial looking at whether the treatment is safe, well-tolerated, and shows initial benefits in adults with the condition, particularly those at higher risk of their kidney disease getting worse.
United States · United Kingdom